首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Mouse lymphoma thymidine kinase gene mutation assay: meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment.
【24h】

Mouse lymphoma thymidine kinase gene mutation assay: meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment.

机译:小鼠淋巴瘤胸腺嘧啶核苷激酶基因突变测定:国际基因毒性测试研讨会,旧金山,2005年,会议,关于24小时治疗的建议。

获取原文
获取原文并翻译 | 示例
       

摘要

The Mouse Lymphoma Assay (MLA) Workgroup of the International Workshop on Genotoxicity Testing (IWGT), comprised of experts from Japan, Europe and the United States, met on September 9, 2005, in San Francisco, CA, USA. This meeting of the MLA Workgroup was devoted to reaching a consensus on issues involved with 24-h treatment. Recommendations were made concerning the acceptable values for the negative/solvent control (mutant frequency, cloning efficiency and suspension growth) and the criteria to define an acceptable positive control response. Consensus was also reached concerning the use of the global evaluation factor (GEF) and appropriate statistical trend analysis to define positive and negative responses for the 24-h treatment. The Workgroup agreed to continue their support of the International Committee on Harmonization (ICH) recommendation that the MLA assay should include a 24-h treatment (without S-9) in those situations where the short treatment (3-4 h) gives negative results.
机译:由日本,欧洲和美国的专家组成的基因毒性测试国际研讨会(IWGT)的小鼠淋巴瘤测定(MLA)工作组于2005年9月9日在美国加利福尼亚州旧金山举行了会议。 MLA工作组的这次会议致力于就24小时治疗所涉及的问题达成共识。提出了有关阴性/溶剂对照的可接受值(突变频率,克隆效率和悬浮液生长)以及定义可接受的阳性对照响应的标准的建议。关于使用全球评估因子(GEF)和适当的统计趋势分析来定义24小时治疗的阳性和阴性反应也达成了共识。工作组同意继续支持国际协调委员会(ICH)的建议,即在短期治疗(3-4 h)产生阴性结果的情况下,MLA分析应包括24小时治疗(无S-9) 。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号